H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 11.9% of adults in New York have diagnosed diabetes — about even with the U.S. 12% figure. Census population 8,336,817. New York Medicare wound biologics: National Government Services (NGS) (JK). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed New York clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a New York storefront.
Wound Care Dressing Products for Healthcare Providers in New York, NY for clinics & physicians. Compliance support & pricing — contact Hawk Medical.
Two files matter before you open a box of wound care dressing products in New York: (1) CDC PLACES (2023, crude) estimates 11.9% of adults in New York have diagnosed diabetes — about even with the U.S. 12% figure. (2) New York Part B wound biologics are reviewed by National Government Services (NGS) under JK, shared with CT, MA, ME, NH, RI, VT. We help with the second file. We do not pretend to be a New York storefront.
National Wound Care Dressing Products for Healthcare Providers notes (how the product actually works)10.6% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. A city of 1M+ with 8,336,817 residents will still mix those payers. CDC PLACES (2023, crude) estimates 11.9% of adults in New York have diagnosed diabetes — about even with the U.S. 12% figure. Build two utilization policies if you do both cash PRP and Medicare CTPs.
Practices hire us when the fridge is full and the chart is a mess. CDC PLACES (2023, crude) estimates 11.9% of adults in New York have diagnosed diabetes — about even with the U.S. 12% figure. That is a planning input. The work is still receiving, indication language, and not mixing PRP with CTP codes. That is the wound care dressing products account.
CDC PLACES (2023, crude prevalence) estimates 11.9% of adults — about even with the U.S. 12% figure. Obesity is 25.1%; arthritis is 19.9%. That is place-level BRFSS modeling, not a clinic census and not a New York trial.
A 510(k)-cleared device has a different regulatory file than a 361 HCT/P. Do not store, bill, or describe them as the same SKU family. Your SOP should split receiving and indication language.
No. National Government Services (NGS) writes coverage. We train staff on documentation patterns those articles already require (wound measurements, conservative care, units). That is support, not a coverage guarantee.
Yes. Tissue products come from FDA-registered banks with donor screening and lot traceability. Your receiving SOP should file IFU, lot, and indication with the chart. That packet is what JK reviewers and surveyors expect — not a brochure.
Start with one protocol — one joint or one wound type — for 90 days. CDC PLACES (2023, crude) estimates 11.9% of adults in New York have diagnosed diabetes — about even with the U.S. 12% figure. Name a staff owner for photos, lots, and centrifuge logs. Then expand the fridge.
Contact us to learn how Hawk Medical supports practices in New York, NY.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for New York is JK geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for New York — about even with the U.S. 12% figure. Planning input, not an outcomes claim.
New York Part B wound biologics follow this contractor (siblings: CT, MA, ME, NH, RI, VT). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in New York. Useful for joint-program math; still needs a diagnosis and privileging.
No New York storefront. Joe Bradley is an active practice owner. wound care dressing products stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.